Drug details
Leustatin (cladribine injection for intravenous infusion only)
type of Antineoplastics, Antimetabolite
Leustatin (cladribine) Injection is an antineoplastic (anticancer) medication used to treat hairy cell leukemia (a type of blood cancer). Leustatin is available in generic form.
This drug may have the following side effects:
- headache
- cough
- nausea
- diarrhea
- vomiting
- tiredness
- constipation
- skin rash
- weakness
- injection site reactions (pain, swelling, irritation, and redness)
- itching or
The following drugs are related to Leustatin, either as a replacement or used together:
- Erwinaze (asparaginase erwinia chrysanthemi)
- Treanda (bendamustine hydrochloride injection)
- Bendeka (bendamustine hydrochloride injection)
- Bosulif (bosutinib tablets)
- Busulfex (busulfan)
- Copiktra (duvelisi capsules)
- Sprycel (dasatinib)
- Fludara (fludarabine)
- Oforta (fludarabine phosphate tablets)
- Gazyva (obinutuzumab injection)
- Zydelig (idelalisib tablets)
- Jakafi (ruxolitinib)
- Marqibo (vincristine sulfate liposome injection)
- Tasigna Capsules (nilotinib capsules)
- Synribo (omacetaxine mepesuccinate)
- Rituxan (rituximab)
The following supplements are related to Leustatin, and may be used together with the drug:
- Saccharomyces Boulardii (s.)
- Arsenic (s.)
- Transfer Factor (s.)